Hogy Medical Co.,Ltd.
HGYMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -164.17 | -0.16 | 0.07 | 7.01 |
| FCF Yield | -0.00% | 0.05% | 1.60% | 0.05% |
| EV / EBITDA | 6,628.74 | 30.11 | 39.88 | 27.58 |
| Quality | ||||
| ROIC | 0.00% | 0.79% | 0.61% | 1.02% |
| Gross Margin | 31.29% | 34.84% | 29.87% | 34.03% |
| Cash Conversion Ratio | 7.09 | 0.37 | -3.17 | 1.53 |
| Growth | ||||
| Revenue 3-Year CAGR | 367.78% | 414.79% | 414.82% | 414.27% |
| Free Cash Flow Growth | -103.38% | -97.32% | 3,087.80% | -98.76% |
| Safety | ||||
| Net Debt / EBITDA | -721.45 | -3.80 | -4.46 | -2.58 |
| Interest Coverage | 12.11 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.62 | 0.64 | 0.75 |
| Cash Conversion Cycle | 28,164.65 | 149.62 | 185.80 | 176.54 |